Search results
Why AbbVie (ABBV) is a Great Dividend Stock Right Now
Zacks· 6 days agoCash flow can come from bond interest, interest from other types of investments, and of course, dividends. A dividend is the distribution of a company's earnings paid out to shareholders; it's ...
Pharma Stock Roundup: FDA Nod to MRK's New Jab & Expanded Use of ABBV & AZN Drugs
Zacks via Yahoo Finance· 4 days agoFDA approves Merck's (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive and the expanded use...
Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years - AbbVie (NYSE:ABBV)
Benzinga· 4 days agoAbbVie ABBV has outperformed the market over the past 10 years by 1.28% on an annualized basis producing an average annual return of 12.11%. Currently, AbbVie< ...
US law firm Motley Rice appeals $396 mln opioid fee award
Reuters· 8 hours agoU.S. law firm Motley Rice is appealing its award of $396 million for its work on litigation against...
Here's Why You Should Consider Buying Alvotech (ALVO) Stock
Zacks· 24 hours agoAlvotech has a commercialization partnership with Teva Pharmaceuticals (TEVA Quick QuoteTEVA...
Hot Summer Dividends: 3 Sizzling Stocks to Buy for Reliable Income
InvestorPlace· 13 hours agoYes, I want the stock market to fall and fall hard. The last market crash was brought on by the...
Gateway - Quartz
Quartz· 7 days agoHumira, a monoclonal antibody used to treat arthritis among other conditions, is the most lucrative drug in history. Since entering the market in 2003, it has made its manufacturer an estimated ...
U.S. FDA Approves SKYRIZI® (risankizumab-rzaa) for Ulcerative Colitis, Expanding AbbVie's Portfolio...
Morningstar· 6 days agoApproval supported by two Phase 3 clinical trials that evaluated SKYRIZI® for the treatment of moderate to severe ulcerative colitis: a 12-week induction study, INSPIRE,1 and a 52-week maintenance study, COMMAND2Data showed that clinical remission,
Pharma Stock Roundup: FDA Nod to MRK's New Jab & Expanded Use of ABBV & AZN Drugs
Zacks· 4 days agoFDA approves Merck's (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive and the expanded use of AbbVie's (ABBV) Skyrizi and AstraZeneca's (AZN) Imfinzi.
Gateway - Quartz
Quartz· 7 days agoPharmaceutical giant AbbVie was able to delay competition to its blockbuster arthritis drug, Humira, into the US market for many years. Although biosimilars will sell at a ...